These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6152433)

  • 1. Clinical efficacy, extrapyramidal symptoms and serum levels: influence of administration schedules and concomitant drugs on serum bromperidol concentrations.
    Fujii Y; Tateyama M; Kamisada M; Tanoue A; Takamiya M; Nakajima S; Itoh H
    Folia Psychiatr Neurol Jpn; 1984; 38(2):121-36. PubMed ID: 6152433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma concentrations of bromperidol and its reduced metabolite with levomepromazine, but not with thioridazine.
    Suzuki A; Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Kaneko S; Inoue Y; Shibata M; Ikeda K
    Ther Drug Monit; 1997 Jun; 19(3):261-4. PubMed ID: 9200764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment with bromperidol in schizophrenic patients].
    Ellerman LA
    Acta Psiquiatr Psicol Am Lat; 1988 Dec; 34(4):335-40. PubMed ID: 2908218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No effect of the anticholinergic drugs trihexyphenidyl and biperiden on the plasma concentrations of bromperidol and its reduced metabolite.
    Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Suzuki A; Kaneko S; Inoue Y; Shibata M; Ikeda K
    Ther Drug Monit; 1997 Apr; 19(2):165-8. PubMed ID: 9108644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prolactin concentrations between haloperidol and bromperidol treatments in schizophrenic patients.
    Yasui-Furukori N; Kondo T; Suzuki A; Mihara K; Kaneko S; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):575-8. PubMed ID: 11999910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with bromperidol in schizophrenic patients].
    Ellerman LA
    Acta Psiquiatr Psicol Am Lat; 1989; 35(1-2):23-30. PubMed ID: 2634329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between steady-state plasma concentrations (Css) of bromperidol and haloperidol.
    Yasui N; Otani K; Kondo T; Suzuki A; Furukori H; Kaneko S; Inoue Y
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Apr; 22(3):485-92. PubMed ID: 9612845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic treatment of schizophrenia with injectable bromperidol decanoate].
    Suárez Richards M
    Acta Psiquiatr Psicol Am Lat; 1985 Sep; 31(3):222-8. PubMed ID: 2870608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of bromperidol and perphenazine.
    Woggon B; Angst J
    Int Pharmacopsychiatry; 1978; 13(3):165-76. PubMed ID: 355182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-blind comparison of bromperidol and sulpiride in hospitalized schizophrenics.
    Yamagami S; Hirayama E; Mui K; Okuno M; Kioka T; Soma T; Ohno K
    Acta Psychiatr Belg; 1993; 93(4):236-44. PubMed ID: 7913572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects and side-effects of bromperidol in comparison with other antipsychotic drugs.
    Woggon B
    Acta Psychiatr Belg; 1978; 78(1):155-72. PubMed ID: 347878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of bromperidol on the five dimensions of schizophrenic symptoms.
    Yasui-Furukori N; Kondo T; Ishida M; Furukori H; Suzuki A; Kaneko S; Inoue M; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):53-7. PubMed ID: 11853119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients.
    Blin O; Azorin JM; Bouhours P
    J Clin Psychopharmacol; 1996 Feb; 16(1):38-44. PubMed ID: 8834417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
    Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN
    Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary note on the antipsychotic efficacy of bromperidol.
    Bataille M
    Acta Psychiatr Belg; 1978; 78(1):173-9. PubMed ID: 347879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report.
    Suzuki A; Kondo T; Mihara K; Yasui-Furukori N; Otani K; Furukori H; Kaneko S; Inoue Y
    Eur Arch Psychiatry Clin Neurosci; 2001; 251(2):57-9. PubMed ID: 11407439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
    Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
    Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a clinical trial with bromperidol C-C 2489/21.
    Weiser G
    Acta Psychiatr Belg; 1978; 78(1):102-9. PubMed ID: 347873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of haloperidol pyridinium and reduced haloperidol pyridinium in schizophrenic patients: no relationship with clinical variables during short-term treatment.
    Ulrich S; Neuhof S; Braun V; Danos P; Pester U; Hoy L
    J Clin Psychopharmacol; 2000 Apr; 20(2):210-9. PubMed ID: 10770460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The characteristics of side-effects of bromperidol in schizophrenic patients.
    Yasui-Furukori N; Kondo T; Ishida M; Tanaka O; Mihara K; Kaneko S; Otani K
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):103-6. PubMed ID: 11929578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.